Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2024-09-09 00:00:00 ET · period of report 2024-09-05 · accession 0001415889-24-023094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-09 | 2024-09-05 | TVTX | Dube Eric M | CEO, Dir | A - Grant | $0.00 | +32.5K | 383.1K | +9% | $0 | |
| 2024-09-09 | 2024-09-09 | TVTX | Dube Eric M | CEO, Dir | S - Sale | $11.52 | -21.1K | 362.0K | -6% | -$243.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-05 | A | A | 32,500 | $0.00 | 383,100 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-09 | S | D | 21,125 | $11.52 | 361,975 | D | — | — |